Key result
Incorporation of the EYH peptide into Ad and AAV capsids significantly and selectively enhanced gene delivery to primary human arterial smooth muscle cells by up to 70-fold.
Modification of Ad and AAV vectors with the EYH peptide significantly enhances targeted gene delivery to human vascular smooth muscle cells, offering potential for improved local vascular gene therapy.
Answers are grounded in this paper and cite their sources.
May enable targeted vascular gene therapy; hypothesis-generating and requires in vivo validation before clinical use.
The vascular smooth muscle cell (SMC) is integral to the pathogenesis of neointimal formation associated with late vein graft failure, in-stent restenosis, and transplant arteriopathy. Viral vectors transduce SMC with low efficiency and hence, there is a need for improvement. We aimed to enhance the efficiency and selectivity of gene delivery to human SMC. Targeting ligands were identified using phage display on primary human saphenous vein SMC with linear and cyclic libraries. Two linear peptides, EYHHYNK (EYH) and GETRAPL (GET), were incorporated into the HI loop of adenovirus (Ad) fibers and the capsid protein of adeno-associated virus-2 (AAV-2). Exposure of human venous SMC to EYH-modified (but not the GET-modified) Ad vector resulted in a significant increase in transgene expression levels at short, clinically relevant exposure times. Similarly, the EYH-modified AAV vector resulted in enhanced gene transfer to human venous SMC but not endothelial cells in a time- and dose-dependent manner. The EYH-modified AAV vector also enhanced (up to 70-fold) gene delivery to primary human arterial SMC. Hence, incorporation of EYH into Ad and AAV capsids resulted in a significant and selective enhancement in transduction of SMC and has implications for improving local gene delivery to the vasculature.
No takes yet. Share an insight, caveat, or question.
Work et al. (2003) studied Vascular smooth muscle cell transduction. EYH-modified Ad and AAV vectors vs. GET-modified vectors was evaluated on Transgene expression levels and gene transfer efficiency (up to 70-fold enhancement). Incorporation of the EYH peptide into Ad and AAV capsids significantly and selectively enhanced gene delivery to primary human arterial smooth muscle cells by up to 70-fold.
Synapse has enriched 10 related papers. Consider them for comparative context: